MetaVia Total Liabilities and Share Holders Equity 2015-2024 | MTVA

MetaVia total liabilities and share holders equity from 2015 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.

MetaVia Total Liabilities and Share Holders Equity 2015-2024 | MTVA

MetaVia total liabilities and share holders equity from 2015 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$151.4B
Bristol Myers Squibb (BMY)$119.8B
Gilead Sciences (GILD)$119.1B
Vertex Pharmaceuticals (VRTX)$113.7B
CSL (CSLLY)$83.5B
Regeneron Pharmaceuticals (REGN)$75.5B
GSK (GSK)$72.7B
Argenex SE (ARGX)$39.5B
Alnylam Pharmaceuticals (ALNY)$35.3B
BioNTech SE (BNTX)$29B
BeiGene (ONC)$22.2B
Biogen (BIIB)$21B
Illumina (ILMN)$20.9B
Moderna (MRNA)$15.7B
Incyte (INCY)$14.2B
Insmed (INSM)$14B
Intra-Cellular Therapies (ITCI)$13.5B
Genmab (GMAB)$13.1B
Genmab (GNMSF)$12.9B
BioMarin Pharmaceutical (BMRN)$12.1B
Bio-Techne Corp (TECH)$11.4B
Vaxcyte (PCVX)$11.1B
Sarepta Therapeutics (SRPT)$11B
Exact Sciences (EXAS)$10.2B
Swedish Orphan Biovitrum (BIOVF)$10.1B
Bio-Rad Laboratories (BIO.B)$10B
QIAGEN (QGEN)$9.7B
Repligen (RGEN)$9.5B
Exelixis (EXEL)$9.4B
Roivant Sciences (ROIV)$8.1B